【#Xiangxue Pharmaceutical and Others Ordered to Resume Enforcement of 152 Million Yuan#】
According to US Stock Research, Tianyancha legal litigation information shows that recently, Xiangxue Pharmaceutical (300147) has added a new enforcement resumption notice, involving an enforcement amount of over 152 million yuan related to a financial leasing contract dispute. Other parties subject to enforcement include Guangzhou Kunlun Investment Co., Ltd. and Guangzhou Xianglan Health Industry Co., Ltd. The enforcement court is the Huangpu District People's Court of Guangzhou.
Tianyancha risk information indicates that Xiangxue Pharmaceutical currently has 10 enforcement notices, with a total enforcement amount exceeding 1 billion yuan. Additionally, the company has multiple consumption restriction orders, enforcement default records (laolai), and equity freeze notices.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
